Loading...

Media is loading
 

Date of Award

Spring 2025

Degree Name

Master of Medical Science (Physician Assistant)

Department

Physician Assistant; College of Health Sciences

First Advisor

Jacinta Hollinger

Abstract

Approximately 20% of Americans will receive a cancer diagnosis in their lifetime, with many facing intense therapy regimens that often yield poor outcomes. This paper aims to explore when and how to use Mebendazole—a commonly prescribed antihelmintic—as a repurposed anti-tumoral adjunct treatment in chemotherapy regimens, specifically; ovarian cancer, pancreatic cancer, and brain cancer.

Share

COinS
 

Enhancing Cancer Treatment with Mebendazole: Strategies for Clinical Implementation through Shared Decision Making

Approximately 20% of Americans will receive a cancer diagnosis in their lifetime, with many facing intense therapy regimens that often yield poor outcomes. This paper aims to explore when and how to use Mebendazole—a commonly prescribed antihelmintic—as a repurposed anti-tumoral adjunct treatment in chemotherapy regimens, specifically; ovarian cancer, pancreatic cancer, and brain cancer.